MIJO KIM: Open Payments
NPI 1851000616 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,414 in 70 payments from 20 companies in 2025. Trend: 2023 $1,990 · 2024 $2,644 · 2025 $1,414
Food & beverage: $1,414
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $239 |
| PFIZER INC. | 9 | $176 |
| Novo Nordisk Inc | 8 | $142 |
| Otsuka America Pharmaceutical, Inc. | 7 | $141 |
| AstraZeneca Pharmaceuticals LP | 4 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $87 |
| Viatris Specialty LLC | 3 | $80 |
| Astellas Pharma US Inc | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Aimmune Therapeutics, Inc. | 3 | $49 |
Products named: REXULTI, NURTEC ODT, AIRSUPRA, VRAYLAR, Kerendia, Ozempic, YUPELRI, UBRELVY.
Industry payments across WI — which companies pay providers there.
